Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01183403

NCT01183403
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease, confirmed through camera tests (endoscopy), imaging, or tissue samples
  • You have a narrowing (stricture) in the small bowel (in the part called the jejunum or ileum), found through imaging or a camera test
  • You have been experiencing significant symptoms of bowel blockage, rated 3 or higher on a 0–6 scale, over the past 8 weeks
  • Previous treatments with steroids and/or immune-suppressing medications have not worked well enough, and your doctor feels you are ready for a type of medication called anti-TNF therapy

Who may not be able to join:

  • You have a complete bowel blockage that has not improved
  • You have previously been treated with anti-TNF medications
  • You have a pocket of infection (abscess) inside or around your abdomen
  • You currently have an active infection of any kind
  • You had a serious infection within the last 2 months
  • You have untreated latent (inactive/hidden) tuberculosis
  • You have heart failure
  • You have had an active cancer diagnosis within the last 5 years
  • You have a disease affecting the protective coating around your nerves (such as multiple sclerosis) (confirm with trial site)
  • Your Crohn's disease medication (such as azathioprine, mercaptopurine, methotrexate, or thalidomide) has been changed or adjusted in the last two months
  • You are unable to have an MRI scan of the bowel or a special type of ultrasound scan using a contrast dye

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Registry
clinicaltrials_gov
Start date
1 January 2010
Est. completion
1 July 2012

Where this trial is recruiting

🇧🇪 Belgium 🇫🇷 France

Primary endpoints

% of failure defined by the development of at least one of events (obstructive symptoms, activity of the disease..)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov